Susana Armesto

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Dermatologic therapy

Life (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Olveira, Salvador Augustin, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez-Pérez, Susana Armesto, Eva Vilarrasa, Isabel Belinchón-Romero, Pedro Herranz, Javier Crespo, Francisco Guimerá, Lara Gómez-Labrador, Víctor Martín, José Manuel Carrascosa
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life (Basel, Switzerland) 13 (2) (2023)
Antonio Olveira, Salvador Augustin, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez-Pérez, Susana Armesto, Eva Vilarrasa, Isabel Belinchón-Romero, Pedro Herranz, Javier Crespo, Francisco Guimerá, Lara Gómez-Labrador, Víctor Martín, José Manuel Carrascosa
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life (Basel, Switzerland) 13 (2) (2023)
Antonio Olveira, Salvador Augustin, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez-Pérez, Susana Armesto, Eva Vilarrasa, Isabel Belinchón-Romero, Pedro Herranz, Javier Crespo, Francisco Guimerá, Lara Gómez-Labrador, Víctor Martín, José Manuel Carrascosa
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life (Basel, Switzerland) 13 (2) (2023)
Antonio Olveira, Salvador Augustin, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez-Pérez, Susana Armesto, Eva Vilarrasa, Isabel Belinchón-Romero, Pedro Herranz, Javier Crespo, Francisco Guimerá, Lara Gómez-Labrador, Víctor Martín, José Manuel Carrascosa
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life (Basel, Switzerland) 13 (2) (2023)
Susana Armesto, Carmen González Vela, Julia Sánchez, Aitziber Illaro, Jesús Mayorga, Ana E López Sundh, Cristina Naharro Fernández, Natalia Palmou, Cristina Gómez-Fernández, Marcos A González López, Miguel A González-Gay
Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic. Dermatologic therapy 33 (6) (2020)
Rubén Queiro Silva, Susana Armesto, Carmen González Vela, Cristina Naharro Fernández, Miguel Angel González-Gay
COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain. Dermatologic therapy 33 (6) (2020)
Iván Ferraz-Amaro, Diana Prieto-Peña, Natalia Palmou-Fontana, David Martínez-López, Laura de Armas-Rillo, Alicia García-Dorta, Belen Atienza-Mateo, Ricardo Blanco-Alonso, Susana Armesto, Miguel Angel González-Gay
The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis. Medicina (Kaunas, Lithuania) 56 (8) (2020)
Susana Armesto, Carmen González Vela, Marco Antonio González López
Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era. Dermatologic therapy 33 (4) (2020)
Pablo Munguía-Calzada, Marta Drake-Monfort, Susana Armesto, Leandra Reguero-Del Cura, Ana Elisabet López-Sundh, Marcos Antonio González-López
Psoriasis flare after influenza vaccination in Covid-19 era: A report of four cases from a single center. Dermatologic therapy 34 (1) (2020)

Susana Armesto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Susana Armesto